Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.04 USD
Change Today 0.00 / 0.00%
Volume 10.3M
MJNA On Other Exchanges
As of 5:20 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

medical marijuana inc (MJNA) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/4/14 - $0.21
52 Week Low
07/27/15 - $0.04
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDICAL MARIJUANA INC (MJNA)

medical marijuana inc (MJNA) Related Bloomberg News

View More Bloomberg News

medical marijuana inc (MJNA) Related Businessweek News

No Related Businessweek News Found

medical marijuana inc (MJNA) Details

Medical Marijuana, Inc., an investment holding company, operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products. In addition, the company provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products. Medical Marijuana, Inc. was incorporated in 2003 and is headquartered in Poway, California.

46 Employees
Last Reported Date: 05/12/15
Founded in 2003

medical marijuana inc (MJNA) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medical marijuana inc (MJNA) Key Developments

CannaVEST Corp. Settles All Outstanding Litigation with Medical Marijuana, Inc., HempMeds PX, LLC, Kannaway, LLC, General Hemp, LLC, HDDC Holdings, LLC, Rabbit Hole Technologies, LLC, Hemp Deposit and Distribution Corporation and MJNA Holdings, LLC

On July 14, 2015, and upon approval of the Board of Directors of CannaVEST Corp., the company entered into a settlement agreement with Medical Marijuana, Inc., HempMeds PX, LLC, Kannaway, LLC, General Hemp, LLC, HDDC Holdings, LLC, Rabbit Hole Technologies, LLC, Hemp Deposit and Distribution Corporation and MJNA Holdings, LLC, pursuant to which the company settled all outstanding litigation between the company and the MJNA Parties. Pursuant to the terms of the settlement agreement, the MJNA Parties have agreed, jointly and severally, to pay to the company the sum of $750,000, payable by delivery of $150,000 in cash within 5 business days after the escrow agent confirms receipt of all closing deliverables under the Settlement Agreement and $600,000 by delivery of a Secured Promissory Note, bearing interest at 6% per annum, payable in 6 equal monthly installments of $101,757.27 commencing on August 15, 2015. The Note is secured by the pledge of shares of the Company's stock held by PhytoSPHERE Systems, LLC, as a third party beneficiary of the Settlement Agreement. Pursuant to the terms of the Settlement Agreement, Hemp Deposit and Distribution Corporation and the Company entered into an Assignment of Domain Name Rights whereby HDDC transferred and assigned certain domain names associated with the Company's business to the Company. Also, the Company and Medical Marijuana, Inc. entered into a Trademark Assignment, whereby the Company transferred and assigned to MJNA all of its right, title and interest in and to the trademarks Real Scientific, Real Scientific Hemp Oil Nutritional Supplement & Design, RSHO, Cannabis Beauty, Cannabis Beauty Defined and Cannabis Beauty Defined & Design, including all goodwill associated therewith.

Medical Marijuana, Inc. Announces Consolidated Sales Results for the Year 2014

Medical Marijuana, Inc. announced consolidated sales results for the year 2014. Overall consolidated product sales income of $14,522,892 compared to $5,059,924 for the year ending 2013.

Medical Marijuana, Inc. Announces Executive and Management Changes

Medical Marijuana, Inc. announced the appointment of cannabis industry veteran and finance expert Dr. Stuart Titus as President and Chief Executive Officer, along with the appointment of four new members of the Board of Directors. In addition to his officer role, Dr. Titus was appointed as a Member of the Board of Directors. Dr. Stuart Titus, Ph.D., is an industry icon and innovator, having been involved in all aspects of the medical marijuana and industrial hemp industries, Dr. Titus was the number seven investor in Medical Marijuana, Inc., having invested in its seed financing. Dr. Titus has been involved in the development and investment of several cannabis and industrial hemp businesses. Dr. Titus is the co-founder and President of General Hemp, LLC which with Titus at the helm has managed the emergence and growth of several other companies, including CannaVest, KannaLife Sciences Inc. (Board Member) and KannaWAY. Dr. Titus' expertise in finance was forged on Wall Street, where he worked as a bond trader for 11 years, managing a trading and underwriting department as a V.P. for CS First Boston Corp. Robert L. Cunningham, Member, Board of Directors: Robert "Bob" Cunningham has over 40 years of executive management experience in financial services and venture capital. He currently is CEO of Preferred Dealer Programs (PDP), a venture-funded partnership with Crosscheck Inc. Prior to joining PDP, Mr. Cunningham was the founding partner in Placer Financial Group. Chris Prine, Member, Board of Directors: Chris Prine has been CEO of Prines Lines since 1994, which acts as a manufacturers' representative for five U.S. furniture-manufacturing companies with distribution worldwide. Mr. Prine has an intrinsic understanding for the world of manufacturing and distribution. From 1988 to 1994, Mr. Prine served as Marketing Director for the Cleator Corporation, an office furniture manufacturer. Dr. Timothy R. Scott, Ph.D. Member, Board of Directors: Dr. Timothy Scott brings years of public and private enterprise board-level management experience. Dr. Scott served on the Board of Directors of NatureWell Incorporated, a publicly traded company engaged in the nutraceutical and homeopathic drug industry from September 2001 to May 2008. From April 1998 to June 2000, Dr. Scott served as a member of the Board of Directors of ICH Corporation and as a member of ICH's compensation committee.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MJNA:US $0.04 USD 0.00

MJNA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cannabis Science Inc $0.04 USD +0.006
GW Pharmaceuticals PLC 582.50 GBp +40.50
PharmaCyte Biotech Inc $0.10 USD +0.002
View Industry Companies

Industry Analysis


Industry Average

Valuation MJNA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.3x
Price/Book 0.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICAL MARIJUANA INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at